US 12,257,226 B2
Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals
Florence Guimberteau, Libourne (FR); and Hamadi Karembe, Libourne (FR)
Assigned to Ceva Sante Animale, Libourne (FR)
Appl. No. 17/055,869
Filed by Ceva Sante Animale, Libourne (FR)
PCT Filed May 16, 2019, PCT No. PCT/EP2019/062700
§ 371(c)(1), (2) Date Nov. 16, 2020,
PCT Pub. No. WO2019/219855, PCT Pub. Date Nov. 21, 2019.
Claims priority of application No. 18305607 (EP), filed on May 16, 2018.
Prior Publication US 2021/0220319 A1, Jul. 22, 2021
Int. Cl. A61K 31/295 (2006.01); A61K 9/00 (2006.01); A61K 31/7135 (2006.01); A61K 31/721 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 47/32 (2006.01)
CPC A61K 31/295 (2013.01) [A61K 9/0019 (2013.01); A61K 31/7135 (2013.01); A61K 31/721 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/20 (2013.01); A61K 47/32 (2013.01)] 30 Claims
 
1. A veterinary composition comprising an aqueous colloidal solution of beta-ferric oxyhydroxide, dextran glucoheptonic acid and polyvinyl pyrrolidone.